Pieris Pharmaceuticals Inc (PIRS)
Cours de l'action
Résultats financiers
Value bought
90 derniers jours
Value sold
90 derniers jours
Net insiders buying
90 derniers jours
Trades (buy and sell)
90 derniers jours
Rechercher
| Date de notification | Date de transaction | A/V Type de transaction | Initié et/ou titre |
Nb. d'actions Prix Valeur |
Nombre d'actions | Prix | Valeur | Détails |
|---|---|---|---|---|---|---|---|---|
| 2025-04-10 | 2025-04-09 | A Achat | Administrateur non-exécutif |
1 000
+22.6%
20,2750 472 USD |
1 000 +22.6% | 20,27 | 100 000 USD | |
| 2025-04-10 | 2025-04-09 | A Achat | Administrateur non-exécutif |
1 000
+1.4%
20,1350 325 USD |
1 000 +1.4% | 20,13 | 100 000 USD | |
| 2024-12-19 | 2024-12-18 | A Achat | Administrateur non-exécutif |
4 000
+2.3%
12,9351 720 USD |
4 000 +2.3% | 12,93 | 51 720 USD | |
| 2024-08-12 | 2024-08-12 | A Achat | Actionnaire important |
757
+5.3%
15,8812 023 USD |
757 +5.3% | 15,88 | 12 023 USD | |
| 2024-08-12 | 2024-08-12 | A Achat | Actionnaire important |
2 243
+1.8%
15,8835 624 USD |
2 243 +1.8% | 15,88 | 35 624 USD | |
| 2024-08-12 | 2024-08-09 | A Achat | Actionnaire important |
3 000
+2.4%
14,8944 679 USD |
3 000 +2.4% | 14,89 | 44 679 USD | |
| 2023-05-30 | 2023-05-25 | A Achat | Administrateur non-exécutif |
10 000
+100.0%
0,858 500 USD |
10 000 +100.0% | 0,85 | 8 500 USD | |
| 2022-05-16 | 2022-05-13 | A Achat |
Chief Medical Officer Dirigeant |
6 000
+inf%
1,7110 260 USD |
6 000 +inf% | 1,71 | 10 260 USD | |
| 2021-09-01 | 2021-08-30 | V Vente |
Chief Development Officer Dirigeant |
29 200
-86.3%
5,15150 380 USD |
29 200 -86.3% | 5,15 | 150 380 USD | |
| 2021-09-01 | 2021-08-30 | V Vente |
Chief Development Officer Dirigeant |
9 200
-21.4%
5,0046 000 USD |
9 200 -21.4% | 5,00 | 46 000 USD | |
| 2020-07-22 | 2020-07-21 | V Vente |
Aquilo Capital Management, LLC Actionnaire important |
1 900 000
-34.1%
2,955 605 000 USD |
1 900 000 -34.1% | 2,95 | 5 605 000 USD | |
| 2019-09-10 | 2019-09-06 | V Vente | Actionnaire important |
1 128
-0.4%
4,505 075 USD |
1 128 -0.4% | 4,50 | 5 075 USD | |
| 2019-09-10 | 2019-09-06 | V Vente | Actionnaire important |
25 720
-1.1%
4,50115 725 USD |
25 720 -1.1% | 4,50 | 115 725 USD | |
| 2019-09-10 | 2019-09-06 | V Vente | Actionnaire important |
23 152
-1.0%
4,50104 170 USD |
23 152 -1.0% | 4,50 | 104 170 USD | |
| 2018-09-17 | 2018-09-14 | A Achat |
KIRITSY CHRISTOPHER P |
5 000
+100.0%
5,1125 525 USD |
5 000 +100.0% | 5,11 | 25 525 USD | |
| 2018-05-16 | 2018-05-15 | A Achat |
GERAGHTY JAMES A |
10 000
+100.0%
5,7557 500 USD |
10 000 +100.0% | 5,75 | 57 500 USD | |
| 2018-05-02 | 2018-04-30 | V Vente |
ORBIMED ADVISORS LLC Actionnaire important |
10 400
-21.1%
6,3566 040 USD |
10 400 -21.1% | 6,35 | 66 040 USD | |
| 2018-05-02 | 2018-04-30 | V Vente |
ORBIMED ADVISORS LLC Actionnaire important |
989 600
-18.0%
6,356 283 960 USD |
989 600 -18.0% | 6,35 | 6 283 960 USD | |
| 2018-02-15 | 2018-02-13 | V Vente |
ORBIMED ADVISORS LLC Actionnaire important |
75
-0.2%
8,98674 USD |
75 -0.2% | 8,98 | 674 USD | |
| 2018-02-15 | 2018-02-13 | V Vente |
ORBIMED ADVISORS LLC Actionnaire important |
7 822
-0.1%
8,9870 242 USD |
7 822 -0.1% | 8,98 | 70 242 USD | |
| 2018-01-04 | 2018-01-03 | V Vente |
ORBIMED ADVISORS LLC Actionnaire important |
16 128
-24.7%
7,35118 541 USD |
16 128 -24.7% | 7,35 | 118 541 USD | |
| 2018-01-04 | 2018-01-03 | V Vente |
ORBIMED ADVISORS LLC Actionnaire important |
1 693 492
-23.5%
7,3512 447 166 USD |
1 693 492 -23.5% | 7,35 | 12 447 166 USD | |
| 2017-12-20 | 2017-12-18 | V Vente |
ORBIMED ADVISORS LLC Actionnaire important |
1 392
-2.1%
5,707 934 USD |
1 392 -2.1% | 5,70 | 7 934 USD | |
| 2017-12-20 | 2017-12-18 | V Vente |
ORBIMED ADVISORS LLC Actionnaire important |
146 243
-2.0%
5,70833 585 USD |
146 243 -2.0% | 5,70 | 833 585 USD | |
| 2017-08-17 | 2017-08-17 | A Achat |
GERAGHTY JAMES A |
10 000
+inf%
4,8248 200 USD |
10 000 +inf% | 4,82 | 48 200 USD | |
| 2017-08-17 | 2017-08-17 | A Achat |
Reine Allan See Remarks |
20 000
+44.4%
4,8997 800 USD |
20 000 +44.4% | 4,89 | 97 800 USD | |
| 2017-08-17 | 2017-08-16 | A Achat |
Reine Allan See Remarks |
45 000
+inf%
4,79215 550 USD |
45 000 +inf% | 4,79 | 215 550 USD | |
| 2016-06-15 | 2016-06-14 | A Achat |
Matis Louis SVP, Chief Development Officer Dirigeant |
7 915
+379.6%
1,7113 535 USD |
7 915 +379.6% | 1,71 | 13 535 USD | |
| 2016-06-15 | 2016-06-13 | A Achat |
Matis Louis SVP, Chief Development Officer Dirigeant |
2 085
+inf%
1,683 503 USD |
2 085 +inf% | 1,68 | 3 503 USD | |
| 2016-06-15 | 2016-06-13 | A Achat |
Yoder Stephen S. President and CEO Administrateur exécutif |
6 000
+inf%
1,6810 080 USD |
6 000 +inf% | 1,68 | 10 080 USD | |
| 2016-06-15 | 2016-06-13 | A Achat |
DEPTULA-HICKS DARLENE M SVP, Chief Financial Officer Dirigeant |
5 000
+inf%
1,668 300 USD |
5 000 +inf% | 1,66 | 8 300 USD | |
| 2015-07-08 | 2015-07-06 | A Achat |
ORBIMED ADVISORS LLC Administrateur non-exécutif Actionnaire important |
4 717
+7.8%
2,7512 972 USD |
4 717 +7.8% | 2,75 | 12 972 USD | |
| 2015-07-08 | 2015-07-06 | A Achat |
Khuong Chau Quang Administrateur non-exécutif Actionnaire important |
4 717
+7.8%
2,7512 972 USD |
4 717 +7.8% | 2,75 | 12 972 USD | |
| 2015-07-08 | 2015-07-06 | A Achat |
ORBIMED ADVISORS LLC Administrateur non-exécutif Actionnaire important |
495 283
+7.4%
2,751 362 028 USD |
495 283 +7.4% | 2,75 | 1 362 028 USD | |
| 2015-07-08 | 2015-07-06 | A Achat |
Khuong Chau Quang Administrateur non-exécutif Actionnaire important |
495 283
+7.4%
2,751 362 028 USD |
495 283 +7.4% | 2,75 | 1 362 028 USD |